DSM debuts algae-based vaccine production system

Royal DSM N.V. (Euronext:DSM) introduced new technology to produce vaccines using micriobial algae that the company believes will be faster and more efficient than egg- or culture-based methods. DSM said it is exploring potential applications for human vaccines and protein therapeutics. ...